The MiFrAADiF Trial demonstrated a significant improvement in terms of physical HRQoL & a significant reduction of the hospital length of stay after injection of micro-fragmented autologous adipose tissue in diabetic patients’ minor amputations wound.
Health-related quality of life outcomes and hospitalization length of stay after micro-fragmented autologous adipose tissue injection in minor amputations for diabetic foot ulceration (MiFrAADiF Trial): results from a randomized controlled single-center clinical trial.
Wound Healing
December 01, 2021
International Angiology : a Journal of the International Union of Angiology